Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.
16 Jun 2020 - Zelira Therapeutics Limited (ASX:ZLD) Managing Director Ex USA, Dr Richard Hopkins talks about the company's pipeline of products in clinical development targeting insomnia, chronic pain and autism, its model for rapid commercialisation, its go-to-market strategy and first revenues from US licensing partners.
10 Jun 2021 - Calima Energy Limited (ASX:CE1) Executive Chairman Glenn Whiddon provides an update on production at the company's projects in British Columbia and its plans for an active, low-risk drilling program developing proven reserves.
14 July 2023 - Shaw and Partners Chief Investment Officer Martin Crabb takes a look at the current economic situation and what it means for portfolios and investments going forward.
07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management of respiratory conditions and sleep apnoea, discussing its launch of the ResAppDx smartphone-based acute respiratory diagnostic test.
01 Sep 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook, discusses highlights from FY21, including growth in partners and transactions as the company's technology finds greater adoption and new markets.
29 May 2023 - Dr Andrew Tunks, Executive Chairman of Meteoric Resources (ASX:MEI), provides an update on the company's progress, discussing its transition from gold to rare earths, the advantages of ionic clay over hard rock deposits, and promising early results.
19 Sep 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's lead product RECCE 327, including its progress with manufacturing, securing patents and presenting to a global audience.